Emergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators
暂无分享,去创建一个
Neang S. Ly | J. Li | R. Nation | M. Sutton | J. Bulitta | B. Tsuji | Patricia N. Holden | Z. Bulman
[1] S. Gill,et al. Evolution in Fast Forward: a Potential Role for Mutators in Accelerating Staphylococcus aureus Pathoadaptation , 2012, Journal of bacteriology.
[2] A. Wong,et al. Genomics of Adaptation during Experimental Evolution of the Opportunistic Pathogen Pseudomonas aeruginosa , 2012, PLoS genetics.
[3] Boris M. Hartmann,et al. Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300 , 2012, PLoS pathogens.
[4] Shengchang Su,et al. Epistatic Roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in Coping with Reactive Oxygen Species-Induced DNA Damage , 2011, PloS one.
[5] J. Weingarten,et al. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. , 2011, Chest.
[6] M. Sutton,et al. The GO system prevents ROS-induced mutagenesis and killing in Pseudomonas aeruginosa. , 2009, FEMS microbiology letters.
[7] R. Hancock,et al. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. , 2009, FEMS microbiology reviews.
[8] G. Eliopoulos,et al. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. , 2009, The Journal of infectious diseases.
[9] Patrick F. Smith,et al. Attenuated Vancomycin Bactericidal Activity against Staphylococcus aureus hemB Mutants Expressing the Small-Colony-Variant Phenotype , 2008, Antimicrobial Agents and Chemotherapy.
[10] A. Oliver,et al. Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections , 2005, Antimicrobial Agents and Chemotherapy.
[11] Daniel G. Lee,et al. The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Livermore,et al. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] K. Tateda,et al. Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa , 2001, Antimicrobial Agents and Chemotherapy.
[14] D. Livermore,et al. Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. , 2001, The Journal of antimicrobial chemotherapy.
[15] Ronald N. Jones,et al. Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines , 2001, Journal of Clinical Microbiology.
[16] D. Stableforth,et al. The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis , 2000, Drugs.
[17] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[18] T. Beveridge,et al. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion , 1995, Journal of bacteriology.
[19] E. Greenberg,et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Sonstein,et al. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. , 1993, Diagnostic microbiology and infectious disease.
[21] N. Høiby,et al. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. , 1984, Acta paediatrica Scandinavica.
[22] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .